Ernexa Therapeutics (ERNA) Net Equity Issued and Repurchased (2010 - 2026)
Ernexa Therapeutics' Net Equity Issued and Repurchased was -$10.46 million in Q2 2026, compared with $4.93 million a year earlier.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ernexa Therapeutics' Net Equity Issued and Repurchased was $20,000 through Jun 30, 2026, down 99.7% year-over-year; for FY2025, it came in at $4.93 million, up 333.5% from FY2024.
- Net Equity Issued and Repurchased shows a four-year compound annual growth rate of 371.2% (FY2021 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $1.14 million in FY2024, $19.71 million in FY2022 and $10,000 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased in data going back to Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Ernexa Therapeutics | 3.74 Mn | 3.74 Mn | - | -10.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.46 Mn |
| Mar 31, 2026 | 10.48 Mn |
| Jun 30, 2025 | 4.93 Mn |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2022 | 7.71 Mn |
| Mar 31, 2022 | 11.99 Mn |
| Jun 30, 2021 | 10,000.00 |
| Sep 30, 2018 | -6,000.00 |
| Jun 30, 2017 | 219,000.00 |
| Mar 31, 2017 | 1.55 Mn |
| Jun 30, 2015 | 1,000.00 |
| Sep 30, 2014 | 22,000.00 |
| Jun 30, 2014 | 17,000.00 |
| Mar 31, 2014 | 6,000.00 |
| Dec 31, 2013 | 2.34 Mn |
| Sep 30, 2011 | 2,000.00 |
| Mar 31, 2011 | 34,000.00 |
| Sep 30, 2010 | 5,000.00 |
API Access
Ernexa Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();